Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
LOS ANGELES, CA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ( Immix Biopharma , Company , We or Us , Nasdaq:IMMX), a clinical-stage biopharmaceutical company trailblazing cell...